This brand name is authorized in Japan
The drug SUJANU contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Sitagliptin
UNII TS63EW8X6F - SITAGLIPTIN PHOSPHATE
|
|
Sitagliptin is a member of a class of oral anti-hyperglycaemic agents called dipeptidyl peptidase 4 (DPP-4) inhibitors. The improvement in glycaemic control observed with this medicinal product may be mediated by enhancing the levels of active incretin hormones. |
|
2
Ipragliflozin
UNII M6N3GK48A4 - IPRAGLIFLOZIN L-PROLINE
|
|
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 3969107F1022 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
